Answers are grounded in this paper and cite their sources.
Evaluates optical energy transduction in MAPbI3 thin films, indicating performance and stability challenges.
We report the synthesis of methylammonium lead iodide (MAPbI 3 ) thin films via an emulsion–demulsion (E-LARP) route and provide a comprehensive evaluation of their structural, optical, and optoelectronic properties with emphasis on stability and energy transduction performance. X-ray diffraction and transmission electron microscopy confirm the tetragonal I 4/ mcm phase with nanocrystalline ordering, while elemental mapping and surface analyses reveal intrinsic Pb–I bonding alongside pronounced environmental reactivity. Pristine films exhibit a sharp absorption onset near 770–780 nm and strong photoluminescence consistent with a direct bandgap of ∼1.55 eV. Under ambient exposure, optical degradation is marked by hydrate-phase transitions, PbI 2 formation, and defect-state emissions, underscoring the material’s sensitivity to moisture and oxygen. Temperature-dependent photoluminescence further reveals a tetragonal-to-orthorhombic transition below ∼160 K, accompanied by exciton localization and phonon-coupled broadening. Device prototyping with FTO/MAPbI 3 /Ag heterojunctions demonstrates diode-like rectification, high photosensitivity (∼8.3), and measurable quantum efficiency, though photocurrent decay under continuous illumination reflects intrinsic photoinstability. Collectively, these multitechnique investigations establish the emulsion–demulsion route as a viable pathway for MAPbI 3 thin films in optoelectronic applications, while emphasizing the critical need for encapsulation, compositional engineering, and interface passivation to achieve long-term operational stability.
No takes yet. Share an insight, caveat, or question.
Reghunathan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: